Psychosomatic Misdiagnosis Can Have Lasting Negative Impact on Patients
MONDAY, March. 3, 2025 -- Chronic diseases misdiagnosed as psychosomatic can lead to long-term damage to patients' physical and mental well-being, according to a study published online March 3 in Rheumatology.
Melanie Sloan, Dr.P.H., from the University of Cambridge in the United Kingdom, and colleagues examined the impacts of psychosomatic and psychiatric misdiagnoses on patients with systemic autoimmune rheumatic diseases (SARDs). The analysis included 3,396 participants in two SARDs cohorts.
The researchers found that >80 percent of patients reported that perceived psychosomatic and psychiatric misdiagnoses damaged their self-worth, and 72 percent reported that it still upset them. Compared with patients reporting no psychosomatic or psychiatric misdiagnoses, lower mental well-being and higher depression and anxiety levels were seen among patients reporting psychosomatic and/or psychiatric misdiagnoses, along with lower levels of satisfaction with every aspect of medical care. Misdiagnoses were associated with a significantly higher likelihood of underreporting symptoms and health care avoidance, but they were not associated with medication adherence.
"Although many doctors were intending to be reassuring in suggesting a psychosomatic or psychiatric cause for initially unexplainable symptoms, these types of misdiagnoses can create a multitude of negative feelings and impacts on lives, self-worth, and care," Sloan said in a statement. "These appear to rarely be resolved even after the correct diagnoses. We must do better at helping these patients heal, and in educating clinicians to consider autoimmunity at an earlier stage."
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.